3 Houston innovators to know this week

who's who

This week's roundup of Houston innovators includes Alessio Lorusso of Roboze, Tobi Smith of All I Do Is Cook, and Pradeep Sharma of the University of Houston. Courtesy photos

Editor's note: In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from 3D printing to food and cooking — recently making headlines in Houston innovation.

Alessio Lorusso, founder and CEO of Roboze

Alessio Lorusso joins the Houston Innovators Podcast to discuss why he chose Houston to set up U.S. operations for his large-scale 3D printing company, and how the city has the potential to become a hub for the industry. Photo via LinkedIn

The hit the pandemic has had on the global supply chain has been a huge hit to so many companies. However, one Italian company with its United States headquarters in Houston, has an alternative for customers — large scale, in-house production. Roboze, which recently completed a multimillion-dollar fundraise, has seen explosive growth due in large part to how COVID-19 has affected the global supply chain over this past two years.

"This was an incredible accelerator for us," says Alessio Lorusso, CEO and founder, on the Houston Innovators Podcast. He adds that, while Roboze has attracted large corporate customers, the business is seeing growth in the small to mid-sized company sector.

"The moment is now," Lorusso says. "The time to integrate printing capabilities and have the possibility to print parts in house is something that needs to be done now." Click here to read more and listen to the podcast.

Tobi Smith, founder of All I Do Is Cook

All I Do Is Cook is on a mission to grow accessibility to Nigerian dishes. Image via allidoiscook.com

Tobi Smith wanted to take his business to the next level — and he found the perfect opportunity to do so. After completing the gBETA accelerator program and winning the grand prize in the ClearCo ClearPitch competition, Smith and his business partner Bethany Oyefeso are transitioning their small business, All I Do Is Cook, into a startup with the ultimate goal of making Nigerian food accessible to everybody.

Smith and Oyefeso came one step closer to that goal when Phoencia, a Houston grocery story, started stocking the startup's condiments in 2021. In that same year, Smith and Oyefesso joined the gBETA accelerator program. Smith described this program as being instrumental in the advancement of their company from a small business to a start up, now at the beginning of their pre-seed funding phase.

“They taught us everything about what it meant to be a start up and connected us with mentors and other individuals working in the food and beverage space,” says Smith. Click here to read more.

Pradeep Sharma, engineering department chair at the University of Houston

Pradeep Sharma, M.D. Anderson Chair Professor and department chair at the University of Houston, was named to the National Academy of Engineering. Photo via uh.edu

The National Academy of Engineering elected its new members, and five local scientists are among the new 133-person cohort — as is Elon Musk, if you were wondering. The appointment is among the highest professional distinctions in an engineer's career.

Pradeep Sharma, M.D. Anderson Chair Professor and department chair, Department of Mechanical Engineering, University of Houston, was recognized for establishing the field of flexoelectricity, leading to the creation of novel materials and devices and insights in biophysical phenomena.

“Nature has provided us very few piezoelectric materials even though their applications in energy harvesting and in making sensors is very important. What we did was use theory to design materials that perform like piezoelectric ones, so that they can create electricity,” says Sharma in the release. Click here to read more.

Why this innovator wants to make Houston a hub for 3D printing

Houston innovators podcast episode 121

When Alessio Lorusso founded his company in 2014, he saw a huge gap in the 3D printing market — and he wanted to be the person to fill it.

Lorusso, CEO and founder of Roboze, shares on the Houston Innovators Podcast, that historically 3D printing has been used for prototypes and testing, before companies decide to turn to larger scale manufacturing — typically done overseas.

"I thought at that time — and still today — that 3D printing needed to demonstrate that it was a real capable technology to produce and use parts instead of prototypes," Lorusso says. "This was my goal — and still is my goal — to bring this technology to the production shop floor."

Now, Roboze works with companies to put their large-scale 3D printer on site to support in-house part and tool creation. Roboze's technology, the ARGO 1000 has the ability to produce parts up to one cubic meter — about 40 inches by 40 inches by 40 inches. This size of output allows for on-demand manufacturing at scale. Additionally, the device uses more sustainable and high-performing super polymers and composites such as PEEK, Carbon PEEK and ULTEM ™ AM9085F.

"We are helping our customers to digitize their inventory," Lorusso says on the podcast, "but this is much more than 3D printing. This is supply chain reshaping. This is a production reshoring."

Roboze, which recently completed a multimillion-dollar fundraise, has seen explosive growth due in large part to how COVID-19 has affected the global supply chain over this past two years.

"This was an incredible accelerator for us," he says, adding that, while Roboze has attracted large corporate customers, the business is seeing growth in the small to mid-sized company sector.

"The moment is now," Lorusso says. "The time to integrate printing capabilities and have the possibility to print parts in house is something that needs to be done now."

Roboze set up its United States headquarters in Houston in the summer of 2020, and has hit the ground running in terms of connecting to the ecosystem. Lorusso observes that some of the city's key industries — health care, aerospace, energy, and transportation — are all ripe for disruption by 3D printing — and by Roboze specifically.

"We are super committed in making Houston one of the most important cities in the U.S. for 3D printing. What we are trying to create is an ecosystem in the city," he says. "There is an incredible potential."

Lorusso shares more on where he sees the future of 3D printing heading and why he's committed to Houston on the podcast. Listen to the full interview below — or wherever you stream your podcasts — and subscribe for weekly episodes.

Roboze has closed its latest round of funding. Photo courtesy of Roboze

Houston 3D printing company closes latest round of funding, plans to hire

money moves

Roboze — an Italian high-performance 3D printing company with its U.S. headquarters in Houston — closed a multimillion-dollar round of funding this month with investments from an international group of leaders from diverse backgrounds.

Investors include Nova Capital, Lagfin, Andrea Guerra, Luigi De Vecchi, Roberto Ferraresi, Luca Giacometti, Denis Faccioli and others, according to a statement.

“We are honored to have a group of investors of this caliber, who strongly believe in the vision of Roboze and in the change of production paradigm that our technology is enabling by replacing metals and producing parts without wasting raw materials," Alessio Lorusso, founder and CEO of Roboze, said in a statement.

Roboze aims to put the funds towards the research and development of a new "super material" developed in the company's R&D facility in Italy, where the company is also building a new chemistry lab.

The company added that it will also be implementing an aggressive hiring plan in 2022, hiring 60 experts in the next 12 to 18 months in fields such as materials science, chemistry, business development, aerospace, medical devices, and field and applications engineering. Half of the new jobs will be based in the U.S. while the others are slated to be located in Italy and Germany.

Roboze specializes in manufacturing industrial 3D printing technology, such as its ARGO1000, which the company says is the largest printer of its kind. Through a process called Metal Replacement 3D Printing, the company uses super polymers and composites like PEEK and Carbon PEEK to create large-scale, end-use parts for an array of industries—from aeronautics equipment to medical manufacturing.

The company currently works with GE, Bosch, and Airbus, among others, and announced in the statement that manufacturing giant Siemens Energy acquired its first 3D printer from the company.

"We think additive manufacturing is playing a key role in digitalization and cost out in the energy sector. At Siemens Energy we evaluated many companies and found that Roboze technology for high temperature polymers has met our engineering qualification and expectations," Andrew Bridges, Service Frame Owner at Siemens Energy, said in a statement. "As a result, we acquired our first machine and look forward to expanding our relationship with Roboze."

Roboze's latest technology is the biggest on the market. Image courtesy of Roboze

Tech company unveils the 'world's largest 3D printer' in Houston

Texas sized

An Italian company that specializes in manufacturing industrial 3D printing technology has released the largest 3D printer on the market. And the company, which has its North American headquarters in Houston, chose the Bayou City to go live with the innovative product.

Roboze revealed the ARGO 1000 — a 3D printer that Roboze is calling the biggest in the world — which will be available for commercial distribution in 2022. The device has a heated chamber designed to produce large-scale parts with super polymers and composites for industrial applications, according to a news release.

"After years of specializing in super polymers and high-temperature composites and paving the future of industrial 3D printing, we are excited to introduce our flagship Production Series solution, ARGO 1000," says Alessio Lorusso, founder and CEO of Roboze, in the release. "Since we announced the opening of our new headquarters in North America earlier this year, we have grown our global customer base and invested in R&D to fulfill customer demand for a much larger 3D heated chamber super polymer printer."

Roboze announced its U.S. HQ just over a year ago. The company told InnovationMap that the new office was intended to grow Roboze's presence in oil and gas. The new industrial-sized printer too will impact the company's presence in the energy industry, as well as aerospace, transportation, medical, and automotive.

The ARGO 1000 has the ability to produce parts up to one cubic meter — about 40 inches by 40 inches by 40 inches. This size of output allows for on-demand manufacturing at scale. Additionally, the device uses more sustainable and high-performing super polymers and composites such as PEEK, Carbon PEEK and ULTEM ™ AM9085F, per the release.

The company's technology, including its industrial automation system and proprietary gear-based (beltless) technology, also allows for the production of parts that are six times more precise than those made with belt-driven printers, reports the release.

"We have gone far beyond prototypes and are now building custom components for miniature satellites, gears for military-grade vessels, and parts for companies developing the nation's sustainable infrastructure," says Lorusso in the release. "Our technologies ensure precise process control is maintained through the automation of every setting and calibration phase, resulting in continuous accuracy, repeatability, and the certification of every single part produced."

Last year, Roboze announced its American headquarters in Houston. Now the company is announcing something big. Photo courtesy of Roboze

Growing Italian company with U.S. HQ in Houston launches new industrial-scale 3D printing

bigger in texas

An Italian-American manufacturer of 3D parts and printers with its U.S. headquarters in Houston is touting what's billed as a first-of-its-kind innovation — an innovation that's helping drive the need for more local workers.

Roboze recently introduced Roboze Automate, and it's being promoted as the world's first industrial automation system to bring customized 3D printing with super polymers and composites into the production workflow.

"As the need for strong, resilient infrastructure in the U.S. and around the world continues to climb, we are bringing 3D manufacturing to a new level of consistency, repeatability, and process control and production speed," Alessio Lorusso, founder and CEO of Roboze, says in an April 12 news release. "Our components-as-a-service approach is upending error-ridden manufacturing fluctuations and materials shortages to support true industrial-scale 3D manufacturing."

Roboze cranks out 3D-printed parts for customers in industries like aerospace and aviation, energy, oil and gas, transportation, defense, and research. It also sells 3D printers to industrial users. Among its customers are aerospace giant Airbus, appliance manufacturer Bosch, industrial conglomerate GE, defense contractor Leonardo, Pennsylvania State University, consumer electronics titan Sony, the U.S. Army, and the University of Colorado.

Last year, Roboze announced it was establishing its U.S. headquarters in Houston to support its U.S. rollout. The company employs 10 people in the U.S. The local operation, at 7934 Breen Dr. in Northwest Houston, features more than 20 industrial-scale 3D printers.

In February, Roboze said it plans to add 100 employees in the U.S. within the next two years; 30 of those new hires are expected to join the company this spring. The new employees will work in areas such as engineering, sales, and marketing. As of April 13, the Roboze website listed a dozen job openings in Houston and nine in Italy. Around the world, Roboze employs nearly 100 people.

"Houston ranks as one of the top U.S. cities for manufacturing plants and industrial employment, and [is] home to exciting scientific initiatives at the Houston Spaceport and Rice University," Lorusso, who now lives in Houston, said in February.

Ad Placement 300x100

Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

CPRIT CEO: Houston’s $2B in funding is transforming cancer research and prevention

fighting cancer

With its plethora of prestigious health care organizations like the University of Texas MD Anderson Cancer Center, UTHealth Houston, and the Baylor College of Medicine, Houston sits at the heart of cancer research and prevention in Texas.

Of course, it takes piles of cash to support Houston’s status as the state’s hub for cancer research and prevention. Much of that money comes from the Cancer Prevention and Research Institute of Texas (CPRIT).

Data supplied by CPRIT shows organizations in Harris County gained $2.3 billion in institute funding from 2009 through 2025, or nearly $145 million per year. That represents almost 60 percent of the roughly $4 billion that CPRIT has granted to Texas institutions over a 16-year period.

“The life sciences ecosystem that has developed and changed in Houston is phenomenal,” Kristen Doyle, who became the agency’s CEO in July 2024, tells InnovationMap. “In the next decade, we will look back and see a great transformation.”

That ecosystem includes more than 1,100 life sciences and biotech companies, according to the Greater Houston Partnership.

Houston plays critical role in clinical trials

Texas voters approved the creation of CPRIT in 2007. Twelve years later, voters agreed to earmark an extra $3 billion for CPRIT, bringing the state agency’s total investment in cancer research and prevention to $6 billion.

To date, CPRIT money has gone toward recruiting 344 cancer researchers to Texas (mainly to Houston) and has supported cancer prevention services for millions of Texans in the state’s 254 counties. CPRIT funding has also helped establish, expand, or relocate 25 cancer-focused companies. In Houston, MD Anderson ranks as the No. 1 recipient of CPRIT funding.

Regarding cancer research, Doyle says Houston plays a critical role in clinical trials.

“[Clinical trials are] something that CPRIT has focused on more and more. Brilliant discoveries are crucial to this whole equation of solving the cancer problem,” Doyle says. “But if those brilliant ideas stay in the labs, then we’ve all failed.”

Researchers conduct more clinical trials in Houston than anywhere else in the U.S., the Greater Houston Partnership says.

Doyle, a 20-year survivor of leukemia, notes that a minority of eligible patients participate in clinical trials for cancer treatments, “and that’s one of the reasons that it takes so long to get a promising drug to market.”

An estimated 7 percent of cancer patients sign up for clinical trials, according to a study published in 2024 in the Journal of Clinical Oncology.

MD Anderson takes on cancer prevention

Doyle also notes that Houston is leading the charge in cancer prevention.

“We get some national recognition for programs that have been developed in Houston that then can be replicated in other parts of the country,” she says.

Much of the work in Houston focusing on cancer prevention takes place at MD Anderson. The hospital reports that it has received more than $725 million from the CPRIT since 2007, representing approximately 18 percent of CPRIT’s total awards.

“These efforts can have profound impact on the lives of patients and their families, and this funding ensures our exemplary clinicians and scientists can continue working together to drive breakthroughs that advance our mission to end cancer,” Dr. Giulio Draetta, chief scientific officer at MD Anderson, said in a November news release, following the most recent CPRIT award for the hospital totalling more than $29 million.

CPRIT funding for Houston institutions supplements the more than $4.5 billion in federal funding for health and life sciences research and innovations that the Houston area received from 2020 to 2024, according to the Greater Houston Partnership.

“We are curing cancer every single day,” Doyle says of CPRIT. “Every step that we are taking — whether that’s funding great ideas or funding the clinical trials that are bringing promising drugs to Texas and to the world — we are making a difference.”

Houston energy tech co. breaks ground on low-cost hydrogen pilot plant

Coming Soon

Houston’s Lummus Technology and Advanced Ionics have broken ground on their hydrogen pilot plant at Lummus’ R&D facility in Pasadena, Texas.

The plant will support Advanced Ionics’ cutting-edge electrolyzer technology, which aims to deliver high-efficiency hydrogen production with reduced energy requirements.

“By demonstrating Advanced Ionics’ technology at our state-of-the-art R&D facility, we are leveraging the expertise of our scientists and R&D team, plus our proven track record of developing breakthrough technologies,” Leon de Bruyn, president and CEO of Lummus, said in a news release. “This will help us accelerate commercialization of the technology and deliver scalable, cost-effective and sustainable green hydrogen solutions to our customers.”

Advanced Ionics is a Milwaukee-based low-cost green hydrogen technology provider. Its electrolyzer converts process and waste heat into green hydrogen for less than a dollar per kilogram, according to the company. The platform's users include industrial hydrogen producers looking to optimize sustainability at an affordable cost.

Lummus, a global energy technology company, will operate the Advanced Ionics electrolyzer and manage the balance of plant systems.

In 2024, Lummus and Advanced Ionics established their partnership to help advance the production of cost-effective and sustainable hydrogen technology. Lummus Venture Capital also invested an undisclosed amount into Advanced Ionics at the time.

“Our collaboration with Lummus demonstrates the power of partnerships in driving the energy transition forward,” Ignacio Bincaz, CEO of Advanced Ionics, added in the news release. “Lummus serves as a launchpad for technologies like ours, enabling us to validate performance and integration under real-world conditions. This milestone proves that green hydrogen can be practical and economically viable, and it marks another key step toward commercial deployment.”

---

This article originally appeared on EnergyCapitalHTX.com.

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.

View All Listings

INNOVATIONMAP EMAILS ARE AWESOME